Dr Reddy's Laboratories rose 1.25% to Rs 3,421.65 at 09:42 IST on BSE after the company launched HAiROOTZ, the first hair growth supplement to be marketed in India as over-the-counter by the company.
The announcement was made after market hours on Friday, 19 June 2015.
Meanwhile, the BSE Sensex was up 207.54 points, or 0.76%, to 27,523.71
On BSE, so far 1,899 shares were traded in the counter, compared with an average volume of 26,873 shares in the past one quarter.
The stock hit a high of Rs 3,422.40 and a low of Rs 3,405.15 so far during the day. The stock hit a 52-week high of Rs 3,808.75 on 10 April 2015. The stock hit a 52-week low of Rs 2,419 on 19 June 2014.
The large-cap pharma firm has equity capital of Rs 85.25 crore. Face value per share is Rs 5.
Dr Reddy's Laboratories HAiROOTZ comes from the same branch of business that markets MINTOPTM, the No. 1 dermatologist recommended brand in the country.
Dr Reddy's Laboratories' consolidated net profit rose 7.7% to Rs 518.84 crore on 10.8% growth in total income to Rs 3887.34 crore in Q4 March 2015 over Q4 March 2014.
Dr Reddy's Laboratories is an integrated global pharmaceutical company. Through its three businesses - Pharmaceutical Services & Active Ingredients, Global Generics and Proprietary Products - Dr. Reddy's offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations.
Powered by Capital Market - Live News
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
